Magenta Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Conference
Get Alerts MGTA Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that Jason Gardner, D.Phil., President and Chief Executive Officer, is scheduled to participate in a panel discussion at the Guggenheim Healthcare Talks 2021 Genomic Medicines & Rare Disease Conference, being held virtually, on Thursday, April 1st, 2021. The panel discussion, Key Advances in Solid Organ and Stem Cell Transplants - Expanding the Market and Moving Away from Lifelong Immunosuppression, will take place at 1:00 p.m. ET.
A live webcast of the panel discussion can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 90 days following the event.
About Magenta Therapeutics
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.
Follow Magenta on Twitter: @magentatx.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005257/en/
Lyndsey Scull, Director, Corporate Communications
202-213-7086
[email protected]
Jill Bertotti, W2O Group
714-225-6726
[email protected]
Source: Magenta Therapeutics
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Everspin Announces Date of First Quarter 2024 Financial Results Conference Call
- Red River Charitable Foundation Announces 2024 Marcy Levesque Women in Technology Scholarship Recipients
- Tour Billion TBC Announces the Imminent Launch of Metahorse Tycoon, a Premier GameFi Experience with Exclusive NFT Minting
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Twitter, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!